Abstract

e14647 Background: Despite initial responsiveness, acquired resistance to both BVZ and chemotherapy in mCRC is universal. We have recently published that, chronically oxaliplatin resistant LoVo cel...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call